EMA — authorised 1 July 1999
- Marketing authorisation holder: GLAXOSMITHKLINE (IRELAND) LIMITED
- Status: approved
EMA authorised Integrilin on 1 July 1999
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 1 July 1999.
GLAXOSMITHKLINE (IRELAND) LIMITED holds the EU marketing authorisation.